Loading company…
OxTium provides biomedical research tools and services, including AI and bioinformatics capabilities.
OxTium provides a platform for biomedical research, including AI model development, bioinformatics services, and translational medicine products. It serves researchers, clinical laboratories, academic institutions, hospitals, and biotechnology companies. Founded in 2022 and based in Shenzhen, China, it closed Series A funding led by GTJA Investment Group in June 2026.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in